Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
:SPLY
SPLY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.16
Previous CloseN/A
Volume19.00K
Average Volume (3M)123.72K
Market Cap
N/A
Enterprise ValueC$915.89K
Total Cash (Recent Filing)6.68M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.06
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding78,823,230
10 Day Avg. Volume98,846
30 Day Avg. Volume123,718
Standard Deviation0.54
R-Squared0.00672
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Origin Therapeutics Holdings, Inc. News
PremiumCompany Announcements
Safe Supply Leads Fight Against Fentanyl Crisis with Strategic Acquisitions
PremiumCompany Announcements
Safe Supply Announces Board Change Amid Strategic Focus
PremiumCompany Announcements
Safe Supply Teams with Greenlane for Toxi Shield Distribution
PremiumCompany Announcements
Safe Supply Streaming Co. Appoints New CFOPremiumCompany Announcements
Safe Supply Expands with Drug Lab 118 Acquisition
PremiumCompany Announcements
Safe Supply Streaming Expands Distribution of Test StripsPremiumCompany Announcements
Safe Supply to Acquire Drug Lab 118 Ltd.---
Options Prices
Currently, No data available
---
Ownership Overview
SPLY FAQ
What was Origin Therapeutics Holdings, Inc.’s price range in the past 12 months?
Origin Therapeutics Holdings, Inc. lowest stock price was C$0.01 and its highest was C$0.16 in the past 12 months.
What is Origin Therapeutics Holdings, Inc.’s market cap?
Currently, no data Available
When is Origin Therapeutics Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Origin Therapeutics Holdings, Inc.’s earnings last quarter?
Origin Therapeutics Holdings, Inc. released its earnings results on Aug 27, 2024. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is Origin Therapeutics Holdings, Inc. overvalued?
According to Wall Street analysts Origin Therapeutics Holdings, Inc.’s price is currently Overvalued.
Does Origin Therapeutics Holdings, Inc. pay dividends?
Origin Therapeutics Holdings, Inc. does not currently pay dividends.
What is Origin Therapeutics Holdings, Inc.’s EPS estimate?
Origin Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Origin Therapeutics Holdings, Inc. have?
Origin Therapeutics Holdings, Inc. has 78,823,230 shares outstanding.
What happened to Origin Therapeutics Holdings, Inc.’s price movement after its last earnings report?
Origin Therapeutics Holdings, Inc. reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Origin Therapeutics Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:SPLY
---
Company Description
Origin Therapeutics Holdings, Inc.
Origin Therapeutics Holdings Inc is an investment company primarily focusing on investments in the psychedelic industry. The Company plans to invest in opportunities involving, where legally permitted, the research, design, development, testing, production, distribution and sale of psychedelics and services related thereto.
---
Technical Analysis
---